Justin Klee Net Worth & Insider Trades

Justin Klee - Co-Chief Executive Officer, Amylyx Pharmaceuticals, Inc

As of March 20, 2023

What is Justin Klee's Net Worth?

The current estimated net worth of Amylyx Pharmaceuticals, Inc's Co-Chief Executive Officer, Justin Klee, is estimated to be about $89.47M . Justin Klee owns about 2,842,617 units of Amylyx Pharmaceuticals, Inc common stock. In the last 2 months at Amylyx Pharmaceuticals, Inc, Justin Klee has sold an estimated value of $3.19M worth.

What is Justin Klee's Past Insider Trading?

Justin Klee's largest purchase order was 5,968 units , worth over $216.63K on January 10, 2023. Justin Klee's largest sale order was 100,000 units , worth over $3.19M on March 20, 2023. In total, Justin Klee has made about 2 transactions over 2 months of their time at Amylyx Pharmaceuticals, Inc. Justin Klee usually trades in March and January, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Justin Klee's' Mailing Address?

  • Mailing address is C/o Amylyx Pharmaceuticals, Inc. 43 Thorndike Street Cambridge MA 02141 MA

What are Amylyx Pharmaceuticals, Inc's Past Insider Trades?

Amylyx Pharmaceuticals, Inc's most recent insider trade came on August 17, 2023 by Gina Mazzariello who sold 6,164 units worth $128.69K . In the last year, insiders at Amylyx Pharmaceuticals, Inc have sold an estimated value of $78.77M and bought an estimated value of $51.11M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Morningside Venture Investments Ltd,  James Frates, Chief Financial Officer,  and Gina Mazzariello, Chief Legal Officer .

Amylyx Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...